Search

everythinglearnresearchcommunity

for

Search:↓

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Key genes regulate hair follicle phase changes in Inner Mongolia cashmere goats.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Exosomal miRNAs from stem cells can help improve skin health and delay aging.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Exosomes may improve skin, scars, hair growth, and fat grafts in plastic surgery, but more research is needed.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Mouse cell exosomes help hair regrowth and wound healing by activating a specific signaling pathway.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Targeting IL-17 could help treat pattern hair loss.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Skin fat plays a key role in immune defense and healing beyond just storing energy.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.